RCM
JBIO
RA Capital Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Sell |
1,062,326
-8,129,766
| -88% | -$81.2M | 0.18% | 44 |
|
|
2025
Q1 | $23.1M | Hold |
9,192,092
| – | – | 0.39% | 38 |
|
|
2024
Q4 | $24.4M | Hold |
9,192,092
| – | – | 0.32% | 52 |
|
|
2024
Q3 | $19.2M | Hold |
9,192,092
| – | – | 0.22% | 55 |
|
|
2024
Q2 | $15.3M | Buy |
9,192,092
+928,110
| +11% | +$1.54M | 0.2% | 55 |
|
|
2024
Q1 | $244M | Hold |
8,263,982
| – | – | 3.11% | 5 |
|
|
2023
Q4 | $187M | Hold |
8,263,982
| – | – | 2.92% | 6 |
|
|
2023
Q3 | $112M | Hold |
8,263,982
| – | – | 2.21% | 8 |
|
|
2023
Q2 | $142M | Hold |
8,263,982
| – | – | 2.68% | 7 |
|
|
2023
Q1 | $167M | Hold |
8,263,982
| – | – | 3.77% | 5 |
|
|
2022
Q4 | $242M | Hold |
8,263,982
| – | – | 4.91% | 3 |
|
|
2022
Q3 | $137M | Hold |
8,263,982
| – | – | 2.92% | 6 |
|
|
2022
Q2 | $129M | Hold |
8,263,982
| – | – | 3.44% | 4 |
|
|
2022
Q1 | $151M | Hold |
8,263,982
| – | – | 3.31% | 3 |
|
|
2021
Q4 | $97.4M | Hold |
8,263,982
| – | – | 1.72% | 16 |
|
|
2021
Q3 | $173M | Hold |
8,263,982
| – | – | 2.4% | 10 |
|
|
2021
Q2 | $189M | Buy |
+8,263,982
| New | +$189M | 3.03% | 6 |
|